知镜 Cognispect · 医学文献与研究工作台

Association of Vaccination With COVID Outcomes in Pregnant People With Autoimmune Diseases: A Retrospective National Cohort Analysis.

Jaferian S, Wilkins K, Qin Q, Anzalone AJ, Lind ML, Sutton A, Hill EL, Patel RC, Singh N, National Clinical Cohort Collaborative (N3C).
Arthritis care & research · 2026-05-18 · PMID 41972809

文献摘要

Objective To evaluate the effectiveness of COVID-19 vaccination in reducing incident and severe COVID-19 among pregnant individuals with autoimmune rheumatic diseases (AIRDs). Methods We conducted a retrospective cohort study using national electronic health records, including 270,811 pregnant individuals aged 15 to 55 years with pregnancies between December 10, 2020, and June 1, 2024. Among them, 4,715 (1.5%) had at least one AIRD (rheumatoid arthritis, spondyloarthritis, or systemic lupus erythematosus). Participants were categorized by AIRD and vaccination status (unvaccinated, initially vaccinated, or booster vaccinated). Time to incident and severe COVID-19 was assessed using adjusted time ratios (TRs), stratified by variant period (pre-Omicron vs Omicron). Results Initial vaccination delayed time to COVID-19 during the pre-Omicron period in individuals with AIRDs (TR: 1.095; 95% confidence interval [CI]: 1.036-1.157) but not during Omicron (TR: 1.039; 95% CI: 0.980-1.102). Booster vaccination was not significantly protective against infection (TR: 1.039; 95% CI: 0.958-1.128) or severe outcomes (TR: 1.119; 95% CI: 0.670-1.867). Compared to vaccinated individuals without AIRDs, those with AIRDs had shorter time to breakthrough infections in both pre-Omicron (TR: 0.940; 95% CI: 0.891-0.991) and Omicron (TR: 0.905; 95% CI: 0.858-0.955) periods and to severe disease during Omicron (TR: 0.631; 95% CI: 0.485-0.821). Conclusion Vaccination is associated with protection against COVID-19 in pregnancy, but its effectiveness is reduced in those with AIRDs, particularly during the Omicron period.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。